567 related articles for article (PubMed ID: 10440262)
1. Epithelial-mesenchymal transition in proliferative vitreoretinopathy: intermediate filament protein expression in retinal pigment epithelial cells.
Casaroli-Marano RP; Pagan R; Vilaró S
Invest Ophthalmol Vis Sci; 1999 Aug; 40(9):2062-72. PubMed ID: 10440262
[TBL] [Abstract][Full Text] [Related]
2. Ultrastructural and immunocytochemical changes in retinal pigment epithelium, retinal glia, and fibroblasts in vitreous culture.
Vinores SA; Campochiaro PA; McGehee R; Orman W; Hackett SF; Hjelmeland LM
Invest Ophthalmol Vis Sci; 1990 Dec; 31(12):2529-45. PubMed ID: 1702409
[TBL] [Abstract][Full Text] [Related]
3. Effect of Robo1 on retinal pigment epithelial cells and experimental proliferative vitreoretinopathy.
Huang L; Xu Y; Yu W; Li Y; Chu L; Dong J; Li X
Invest Ophthalmol Vis Sci; 2010 Jun; 51(6):3193-204. PubMed ID: 20071679
[TBL] [Abstract][Full Text] [Related]
4. Ultrastructural and electron-immunocytochemical characterization of cells in epiretinal membranes.
Vinores SA; Campochiaro PA; Conway BP
Invest Ophthalmol Vis Sci; 1990 Jan; 31(1):14-28. PubMed ID: 1688833
[TBL] [Abstract][Full Text] [Related]
5. Hepatocyte growth factor receptor in human RPE cells: implications in proliferative vitreoretinopathy.
Lashkari K; Rahimi N; Kazlauskas A
Invest Ophthalmol Vis Sci; 1999 Jan; 40(1):149-56. PubMed ID: 9888438
[TBL] [Abstract][Full Text] [Related]
6. Changes in retinal gene expression in proliferative vitreoretinopathy: glial cell expression of HB-EGF.
Hollborn M; Tenckhoff S; Jahn K; Iandiev I; Biedermann B; Schnurrbusch UE; Limb GA; Reichenbach A; Wolf S; Wiedemann P; Kohen L; Bringmann A
Mol Vis; 2005 Jun; 11():397-413. PubMed ID: 15988409
[TBL] [Abstract][Full Text] [Related]
7. Active scatter factor (HGF/SF) in proliferative vitreoretinal disease.
Briggs MC; Grierson I; Hiscott P; Hunt JA
Invest Ophthalmol Vis Sci; 2000 Sep; 41(10):3085-94. PubMed ID: 10967068
[TBL] [Abstract][Full Text] [Related]
8. Galectin-1 influences migration of retinal pigment epithelial cells.
Alge CS; Priglinger SG; Kook D; Schmid H; Haritoglou C; Welge-Lussen U; Kampik A
Invest Ophthalmol Vis Sci; 2006 Jan; 47(1):415-26. PubMed ID: 16384992
[TBL] [Abstract][Full Text] [Related]
9. Expression of E-cadherin by human retinal pigment epithelium: delayed expression in vitro.
Burke JM; Cao F; Irving PE; Skumatz CM
Invest Ophthalmol Vis Sci; 1999 Nov; 40(12):2963-70. PubMed ID: 10549658
[TBL] [Abstract][Full Text] [Related]
10. Proliferative vitreo-retinal disorders: experimental models in vivo and in vitro.
Martini B
Acta Ophthalmol Suppl (1985); 1992; (201):1-63. PubMed ID: 1322004
[TBL] [Abstract][Full Text] [Related]
11. Pathological changes in the vitreoretinal junction 1: epiretinal membrane formation.
Snead DR; James S; Snead MP
Eye (Lond); 2008 Oct; 22(10):1310-7. PubMed ID: 18344963
[TBL] [Abstract][Full Text] [Related]
12. Cell-cell adhesion molecules and the development of an epithelial phenotype in cultured human retinal pigment epithelial cells.
McKay BS; Irving PE; Skumatz CM; Burke JM
Exp Eye Res; 1997 Nov; 65(5):661-71. PubMed ID: 9367646
[TBL] [Abstract][Full Text] [Related]
13. Cytoskeleton in normal and reactive human retinal pigment epithelial cells.
Fuchs U; Kivelä T; Tarkkanen A
Invest Ophthalmol Vis Sci; 1991 Dec; 32(13):3178-86. PubMed ID: 1748549
[TBL] [Abstract][Full Text] [Related]
14. Intravitreal daunomycin induces multidrug resistance in proliferative vitreoretinopathy.
Esser P; Tervooren D; Heimann K; Kociok N; Bartz-Schmidt KU; Walter P; Weller M
Invest Ophthalmol Vis Sci; 1998 Jan; 39(1):164-70. PubMed ID: 9430558
[TBL] [Abstract][Full Text] [Related]
15. The properties of retinal pigment epithelial cells in proliferative vitreoretinopathy compared with cultured retinal pigment epithelial cells.
Abe T; Durlu YK; Tamai M
Exp Eye Res; 1996 Aug; 63(2):201-10. PubMed ID: 8983978
[TBL] [Abstract][Full Text] [Related]
16. EIU in the rat promotes the potential of syngeneic retinal cells injected into the vitreous cavity to induce PVR.
Behar-Cohen FF; Thillaye-Goldenberg B; de Bizemont T; Savoldelli M; Chauvaud D; de Kozak Y
Invest Ophthalmol Vis Sci; 2000 Nov; 41(12):3915-24. PubMed ID: 11053294
[TBL] [Abstract][Full Text] [Related]
17. [Pathomorphology of membranes appearing in proliferative vitreoretinopathies].
Laudańska-Olszewska I; Omulecki W; Dziegielewski K; Pikulski Z; Omulecka A
Klin Oczna; 2006; 108(1-3):28-31. PubMed ID: 16883935
[TBL] [Abstract][Full Text] [Related]
18. Vitreous modulation of gene expression in low-passage human retinal pigment epithelial cells.
Ganti R; Hunt RC; Parapuram SK; Hunt DM
Invest Ophthalmol Vis Sci; 2007 Apr; 48(4):1853-63. PubMed ID: 17389521
[TBL] [Abstract][Full Text] [Related]
19. Expression and upregulation of microtubule-associated protein 1B in cultured retinal pigment epithelial cells.
Esser P; Grisanti S; Kociok N; Abts H; Hueber A; Unfried K; Heimann K; Weller M
Invest Ophthalmol Vis Sci; 1997 Dec; 38(13):2852-6. PubMed ID: 9418739
[TBL] [Abstract][Full Text] [Related]
20. Phenotypic heterogeneity of retinal pigment epithelial cells in vitro and in situ.
Burke JM; Skumatz CM; Irving PE; McKay BS
Exp Eye Res; 1996 Jan; 62(1):63-73. PubMed ID: 8674514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
